Galderma Must Pay Oracea Fees To NYU During Appeal
A New York federal judge ruled Wednesday that Galderma Laboratories Inc. will have to keep paying royalties to New York University for the patents behind rosacea treatment Oracea while the school...To view the full article, register now.
Already a subscriber? Click here to view full article